- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Synonyms: LM 609
Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.
| Name | Citation | Integrin | ILK | Others |
|---|---|---|---|---|
| Cilengitide trifluoroacetate | 70 | |||
| A-205804 | 6 | |||
| GLPG0187 | 1 | |||
| GSK-3008348 HCl | 0 | |||
| Bexotegrast (PLN-74809) | 0 | |||
| Cilengitide | 36 | |||
| OSU-T315 | 1 | |||
| TR-14035 | 0 | |||
| Cyclo(RGDyK) TFA | 14 | |||
| SB273005 | 27 | |||
| RGD (Arg-Gly-Asp) Peptides | 26 | |||
| ILK-IN-3 | 0 | |||
| RGD peptide (GRGDNP) | 1 | caspase-3 | ||
| ATN-161 | 22 | |||
| Cyclo(-RGDfK) TFA | 13 |
| Description |
Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.
|
References |
|---|
| CAS No. | 892553-42-3 |
|---|---|
| Molecular Weight | 144.18 |
| Isotype | Human IgG1 |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.